Significance of Screening the General Population for Potential Cardiovascular Diseases with a Combination Assay of B-type Natriuretic Peptide and High Sensitive Troponin I

Satoshi Sugawa^*

Abbott Japan Co, Ltd, Diagnostics Division, Japan

^*Corresponding Author: Satoshi Sugawa, Abbott Japan Co, Ltd, Diagnostics Division, 3-5-27, Mita, Minato-ku, Tokyo, 108-6305, Japan, Tel: +81345551104, Fax: +81334576735 Email: